申请人:Merck & Co., Inc.
公开号:US06333335B1
公开(公告)日:2001-12-25
The present invention is directed to tetrahydro-imidazopyridinyl compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
本发明涉及抑制戊二氢咪唑吡啶基化合物对戊二烯蛋白转移酶和致癌基因蛋白Ras的基化作用。该发明还涉及包含本发明化合物的化疗组合物以及用于抑制戊二烯蛋白转移酶和致癌基因蛋白Ras基化的方法。